Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors
申请人:Jones Philip
公开号:US20100234374A1
公开(公告)日:2010-09-16
The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts and tautomers thereof. Compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful for treating cellular proliferative diseases, including cancer. They are also useful for treating neurodegenerative diseases, mental retardation, schizophrenia, inflammatory diseases, restenosis, immune disorders, diabetes, cardiovascular disorders and asthma.
本发明涉及式(I)的化合物及其药学上可接受的盐和互变异构体。本发明的化合物是组蛋白去乙酰化酶(HDAC)的抑制剂,可用于治疗细胞增殖性疾病,包括癌症。它们还可用于治疗神经退行性疾病、智力低下、精神分裂症、炎症性疾病、再狭窄、免疫紊乱、糖尿病、心血管疾病和哮喘。